SNHG6 and metabolic dysfunction-associated steatotic liver disease: further discovered that SNHG6 acts as a scaffold facilitating the interaction between FAF2 and mTOR, which in turn promotes cholesterol synthesis and drives the progression of NAFLD to HCC [75].